This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Johnson & Johnson (JNJ)

NYSE: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 74.33B 71.31B 67.22B 65.03B
Cost of Sales 18.85B 18.24B 17.99B 17.20B
Gross Operating Profit 55.48B 53.07B 49.23B 47.83B
Selling, General, and Administrative Expenses 21.95B 21.83B 20.87B 20.97B
Research & Development 8.67B 8.18B 7.66B 7.55B
Operating Income before D & A (EBITDA) 24.85B 23.06B 20.70B 19.31B
Depreciation & Amortization 3.90B 4.10B 3.67B 3.16B
Interest Income 67.00M 74.00M 64.00M 91.00M
Other Income - Net 70.00M -2.50B -1.63B -3.31B
Special Income / Charges 0.00 -1.16B -2.33B 0.00
Total Income Before Interest Expenses (EBIT) 21.10B 15.95B 14.31B 12.93B
Interest Expense 533.00M 482.00M 532.00M 571.00M
Pre-Tax Income 20.56B 15.47B 13.78B 12.36B
Income Taxes 4.24B 1.64B 3.26B 2.69B
Minority Interest 0.00 0.00 -339.00M 0.00
Net Income From Continuing Operations 16.32B 13.83B 10.51B 9.67B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 16.32B 13.83B 10.51B 9.67B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 16.32B 13.83B 10.85B 9.67B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
16.32B 14.41B 11.68B 9.67B
Preferred Dividends
Net Income Available To Common 16.32B 13.83B 10.51B 9.67B
Basic EPS from Continuing Ops. 5.80 4.92 3.94 3.54
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 5.80 4.92 3.94 3.54
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 5.80 4.92 3.94 3.54
Basic Normalized Net Income/Share 5.80 5.13 4.38 3.54
EPS fr Continuing Ops. 5.70 4.81 3.86 3.49
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 5.70 4.81 3.86 3.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 5.70 4.81 3.86 3.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.70 5.01 4.29 3.49
Dividends Paid per Share 2.76 2.59 2.40 2.25
JNJ News

JNJ Johnson & Johnson

Chart of JNJ

Analysts Ratings for JNJ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 2 2 2 2
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET JNJ ANALYST REPORT

Brokerage Partners

JNJ Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs